repros therapeutics (RPRX)

- nasdaq
$15.98 April 17, 2014-04:00 PM ET
Chart_RPRX_365_13.jpg
Chart Type 1D 5D 1M 3M 6M 1Y 2Y 5Y

 

Prev Close: $15.7 Day's Range: $15.36 - $16.2283

Open: $15.6 52wk Range: $13.93 - $29.79

P/E Ratio: 0 Volume: 175,468

Beta: -0.64 Avg Vol (3m): 264,645

Div & Yield: Market Cap(Mil.): 368

EPS (ttm): -1.33 P/E (ttm): -12.02


repros therapeutics News
  • Repros Receives FDA Guidance That It May Proceed To Conduct Phase 1 And 2 Studies Of Oral Proellex
    3/17/2014
  • Repros Therapeutics Announces Addl. Results From ZA-300 Six Month Study Of Androxal In Men With Secondary Hypogonadism
    2/10/2014
  • Repros Meets With FDA To Discuss Data Requirements For Androxal; NDA Submission Remains Anticipated By Year End 2014
    2/6/2014
  • Repros Therapeutics Appoints Michael Suesserman To Board Of Directors
    12/19/2013
  • Repros Therapeutics Says FDA Schedules Face To Face Meeting To Discuss Androxal Efficacy
    11/25/2013

Next 10 Headlines